Vontobel Holding Ltd. Buys New Shares in Heartflow, Inc. $HTFL

Vontobel Holding Ltd. bought a new position in Heartflow, Inc. (NASDAQ:HTFL) during the 3rd quarter, Holdings Channel.com reports. The institutional investor bought 20,500 shares of the company’s stock, valued at approximately $1,020,000.

A number of other institutional investors have also recently bought and sold shares of HTFL. GAMMA Investing LLC raised its stake in Heartflow by 75.1% during the third quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after purchasing an additional 275 shares during the period. Integrated Wealth Concepts LLC acquired a new position in shares of Heartflow in the 2nd quarter valued at $53,000. Essential Partners LLC purchased a new stake in shares of Heartflow during the 1st quarter valued at $57,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Heartflow during the 4th quarter valued at $72,000. Finally, Valeo Financial Advisors LLC acquired a new stake in shares of Heartflow during the 3rd quarter worth $213,000.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on HTFL shares. UBS Group assumed coverage on Heartflow in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 target price on the stock. Wall Street Zen downgraded Heartflow from a “buy” rating to a “hold” rating in a research report on Saturday. Robert W. Baird set a $45.00 price target on Heartflow in a research note on Friday, August 14th. Benchmark restated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Finally, Piper Sandler restated an “overweight” rating and issued a $45.00 price objective (up from $38.00) on shares of Heartflow in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.25.

Insiders Place Their Bets

In other Heartflow news, CEO John Farquhar sold 38,900 shares of the company’s stock in a transaction dated Monday, October 12th. The shares were sold at an average price of $49.57, for a total value of $1,928,273.00. Following the completion of the transaction, the chief executive officer directly owned 283,014 shares of the company’s stock, valued at $14,029,003.98. This represents a 12.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 19,682 shares of the firm’s stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $50.15, for a total value of $987,052.30. Following the sale, the insider owned 79,956 shares of the company’s stock, valued at approximately $4,009,793.40. This trade represents a 19.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 304,105 shares of company stock worth $14,173,800 over the last quarter. 7.70% of the stock is owned by corporate insiders.

Heartflow Trading Up 5.7%

Shares of HTFL stock opened at $51.02 on Tuesday. The company has a market cap of $4.44 billion, a PE ratio of -27.88 and a beta of 2.73. The company’s fifty day simple moving average is $47.70 and its 200-day simple moving average is $35.53. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $54.32.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm had revenue of $64.08 million during the quarter. The firm’s revenue for the quarter was up 47.7% on a year-over-year basis. Equities research analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries and provide noninvasive assessments of blood flow and disease.

The company’s products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.